Jazz Earnings Yield from 2010 to 2025

JAZZ Stock  USD 121.06  2.70  2.18%   
Jazz Pharmaceuticals Earnings Yield yearly trend continues to be fairly stable with very little volatility. Earnings Yield is likely to outpace its year average in 2025. Earnings Yield is the inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company. View All Fundamentals
 
Earnings Yield  
First Reported
2010-12-31
Previous Quarter
0.048
Current Value
0.0504
Quarterly Volatility
0.05048574
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 349.5 M, Other Operating Expenses of 3.9 B or Operating Income of 698.6 M, as well as many indicators such as Price To Sales Ratio of 2.22, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Earnings Yield Growth Pattern

Below is the plot of the Earnings Yield of Jazz Pharmaceuticals PLC over the last few years. It is the inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company. Jazz Pharmaceuticals' Earnings Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Earnings Yield10 Years Trend
Very volatile
   Earnings Yield   
       Timeline  

Jazz Earnings Yield Regression Statistics

Arithmetic Mean0.03
Coefficient Of Variation161.99
Mean Deviation0.04
Median0.05
Standard Deviation0.05
Sample Variance0
Range0.1996
R-Value0.08
Mean Square Error0
R-Squared0.01
Significance0.76
Slope0.0009
Total Sum of Squares0.04

Jazz Earnings Yield History

2025 0.0504
2024 0.048
2023 0.0533
2022 -0.0215
2021 -0.0433
2020 0.0259
2019 0.0618

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Earnings Yield, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Earnings Yield 0.05  0.05 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.